The short version of fatty acid oxidation fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-18. Anything still debated is marked as such rather than presented as settled.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic PPARδ agonist | Not a steroid or a selective androgen receptor modulator. |
| Common synonyms | Cardarine, GW501516, GW-501516, endurobol | Names vary by supplier and literature source. |
| Appearance | White to off-white powder | Consistent with many small-molecule research chemicals. |
| Solubility | Low in water; soluble in DMSO and ethanol | Often prepared in organic solvent for laboratory work. |
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid and energy metabolism. |
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
== Production Sites == IMA Life has four production sites, one located in the outskirts of Bologna, one in Calenzano near Florence, one in Tonawanda, NY (USA) and one in Beijing (China). Apart from its manufacturing plants, it has sales and service centers at Puerto Rico, Brazil, France, Italy, Ireland, China and Japan.
Citrate inhibits phosphofructokinase when tested in vitro by enhancing the inhibitory effect of ATP. However, it is doubtful that this is a meaningful effect in vivo, because citrate in the cytosol is utilized mainly for conversion to acetyl-CoA for fatty acid and cholesterol synthesis. TIGAR, a p53 induced enzyme, is responsible for the regulation of phosphofructokinase and acts to protect against oxidative stress. TIGAR is a single enzyme with dual function that regulates F2,6BP. It can behave as a phosphatase (fructuose-2,6-bisphosphatase) which cleaves the phosphate at carbon-2 producing F6P. It can also behave as a kinase (PFK2) adding a phosphate onto carbon-2 of F6P which produces F2,6BP. In humans, the TIGAR protein is encoded by C12orf5 gene. The TIGAR enzyme will hinder the forward progression of glycolysis, by creating a build up of fructose-6-phosphate (F6P) which is isomerized into glucose-6-phosphate (G6P). The accumulation of G6P will shunt carbons into the pentose phosphate pathway.
Most directly, the 3 September 1984 march was a response to rent increases in the Vaal. In this context, rents included basic housing rent as well as service tariffs and levies, paid to local councils, and they had quadrupled in Vaal since 1977. By 1984, the Vaal Triangle was the most expensive black area in South Africa. The lowest rents in Sebokeng, for example, at R50 per month, were the cheapest in Vaal, but were still higher than the highest rents in Soweto, at R48 per month. Jeremy Seekings argues that most violent confrontations in black townships in the preceding years had, similarly, been driven largely by discontent over local issues, such as rent increases, shack demolitions, or (a particularly emotive issue because of the Group Areas Act) increases in the cost of transport to urban workplaces. The Black Local Authorities Act of 1982, moreover, had fused these local grievances with the indifference and discontent that was popularly directed at black local councillors. The turnout in the 1983 council elections was exceptionally low, at 21 per cent – 10.7 per cent in Soweto – suggesting little buy-in to the council system. However, even many of those who had no principled objection to the Black Local Authorities grew disenchanted in 1984, as local councillors elected in 1983 broke their campaign promises and raised service charges.
Additionally, increasing levels of OGT for O-GlcNAcylation may have therapeutic effects for Alzheimer's disease patients. Brain glucose metabolism is impaired in Alzheimer's disease, and a study suggests that this leads to hyperphosphorylation of tau and degerenation of tau O-GlcNCAcylation. Replenishing tau O-GlcNacylation in the brain along with protein phosphatase could deter this process and improve brain glucose metabolism.
Sources: en.wikipedia.org
=== Education === The families of individuals, and society at large, who have inherited or are at risk of inheriting HD have generations of experience of HD but may be unaware of recent breakthroughs in understanding the disease, and of the availability of genetic testing. Genetic counseling benefits these individuals by updating their knowledge, seeking to dispel any unfounded beliefs that they may have, and helping them consider their future options and plans. The Patient Education Program for Huntington's Disease has been created to help educate family members, caretakers, and those diagnosed with Huntington's disease. Also covered is information concerning family planning choices, care management, and other considerations.
The territory of the Viceroyalty of New Granada became the Republic of Colombia, organized as a union of the current territories of Colombia, Panama, Ecuador, Venezuela, parts of Guyana and Brazil and north of Marañón River. The Congress of Cúcuta in 1821 adopted a constitution for the new Republic. Simón Bolívar became the first President of Colombia, and Francisco de Paula Santander was made Vice President. However, the new republic was unstable and the Gran Colombia ultimately collapsed. Modern Colombia comes from one of the countries that emerged after the dissolution of Gran Colombia, the other two being Ecuador and Venezuela. Colombia was the first constitutional government in South America, and the Liberal and Conservative parties, founded in 1848 and 1849, respectively, are two of the oldest surviving political parties in the Americas. Slavery was abolished in the country in 1851. Internal political and territorial divisions led to the dissolution of Gran Colombia in 1830. The so-called "Department of Cundinamarca" adopted the name "New Granada", which it kept until 1858 when it became the "Confederación Granadina" (Granadine Confederation). After a two-year civil war in 1863, the United States of Colombia was created, which became known as the Republic of Colombia in 1886.
16 January – Analysis shows that Labour would need a record swing of 12.7% in votes at the next general election to win a majority in the House of Commons. Lee Anderson and Brendan Clarke-Smith resign their positions as Deputy Chairmen of the Conservative Party, after saying they would back rebel amendments on the Rwanda bill. Jane Stevenson also resigns as a Parliamentary Private Secretary so she can vote for the amendment. The fifteen-year time limit on voting eligibility for British citizens living abroad is abolished under the Elections Act 2022, enabling a further two million people to register to vote in UK elections. 17 January – The UK government is seeking legal expenses from the Scottish Government over its challenge against the veto of the Gender Recognition Reform (Scotland) Bill. The current session of the 7th Northern Ireland Assembly is suspended following the failure of Democratic Unionist Party to support nominations to elect Mike Nesbitt (UUP) or Patsy McGlone (SDLP) to the role of Speaker of the Northern Ireland Assembly. The Safety of Rwanda (Asylum and Immigration) Bill passes its third reading in the House of Commons with MPs voting 320–276 in favour of the bill. 18 January – The UK Statistics Authority rebuked the prime minister for misleading the public over the backlog of asylum applications, which he said in a social media post had been cleared, while several thousand still remained. The UKSA said the allegation could have affected public trust in the government.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.
It binds to and activates PPARδ, a nuclear receptor that regulates genes related to fatty acid oxidation and energy use. This activation alters transcription in tissues such as skeletal muscle and liver. The full range of downstream effects in humans is not fully established.
No, cardarine is not known to occur naturally in plants, animals, or humans. It is a synthetic molecule produced for laboratory research. Products labeled as cardarine should therefore be treated as manufactured chemicals with variable purity.
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.